247 related articles for article (PubMed ID: 15894466)
1. Reduced insulin-mediated citrate synthase activity in cultured skeletal muscle cells from patients with type 2 diabetes: evidence for an intrinsic oxidative enzyme defect.
Ortenblad N; Mogensen M; Petersen I; Højlund K; Levin K; Sahlin K; Beck-Nielsen H; Gaster M
Biochim Biophys Acta; 2005 Jun; 1741(1-2):206-14. PubMed ID: 15894466
[TBL] [Abstract][Full Text] [Related]
2. Primary defects in lipolysis and insulin action in skeletal muscle cells from type 2 diabetic individuals.
Kase ET; Feng YZ; Badin PM; Bakke SS; Laurens C; Coue M; Langin D; Gaster M; Thoresen GH; Rustan AC; Moro C
Biochim Biophys Acta; 2015 Sep; 1851(9):1194-201. PubMed ID: 25819461
[TBL] [Abstract][Full Text] [Related]
3. Abnormal metabolism flexibility in response to high palmitate concentrations in myotubes derived from obese type 2 diabetic patients.
Kitzmann M; Lantier L; Hébrard S; Mercier J; Foretz M; Aguer C
Biochim Biophys Acta; 2011 Apr; 1812(4):423-30. PubMed ID: 21172433
[TBL] [Abstract][Full Text] [Related]
4. Differential utilization of saturated palmitate and unsaturated oleate: evidence from cultured myotubes.
Gaster M; Rustan AC; Beck-Nielsen H
Diabetes; 2005 Mar; 54(3):648-56. PubMed ID: 15734839
[TBL] [Abstract][Full Text] [Related]
5. Mitochondrial respiration is decreased in skeletal muscle of patients with type 2 diabetes.
Mogensen M; Sahlin K; Fernström M; Glintborg D; Vind BF; Beck-Nielsen H; Højlund K
Diabetes; 2007 Jun; 56(6):1592-9. PubMed ID: 17351150
[TBL] [Abstract][Full Text] [Related]
6. Increased proton leak and SOD2 expression in myotubes from obese non-diabetic subjects with a family history of type 2 diabetes.
Aguer C; Pasqua M; Thrush AB; Moffat C; McBurney M; Jardine K; Zhang R; Beauchamp B; Dent R; McPherson R; Harper ME
Biochim Biophys Acta; 2013 Oct; 1832(10):1624-33. PubMed ID: 23685312
[TBL] [Abstract][Full Text] [Related]
7. The reduced insulin-mediated glucose oxidation in skeletal muscle from type 2 diabetic subjects may be of genetic origin--evidence from cultured myotubes.
Gaster M; Beck-Nielsen H
Biochim Biophys Acta; 2004 Sep; 1690(1):85-91. PubMed ID: 15337174
[TBL] [Abstract][Full Text] [Related]
8. Triacylglycerol accumulation is not primarily affected in myotubes established from type 2 diabetic subjects.
Gaster M; Beck-Nielsen H
Biochim Biophys Acta; 2006 Jan; 1761(1):100-10. PubMed ID: 16442843
[TBL] [Abstract][Full Text] [Related]
9. Prolonged exposure to palmitate impairs fatty acid oxidation despite activation of AMP-activated protein kinase in skeletal muscle cells.
Pimenta AS; Gaidhu MP; Habib S; So M; Fediuc S; Mirpourian M; Musheev M; Curi R; Ceddia RB
J Cell Physiol; 2008 Nov; 217(2):478-85. PubMed ID: 18561258
[TBL] [Abstract][Full Text] [Related]
10. Reduced lipid oxidation in myotubes established from obese and type 2 diabetic subjects.
Gaster M
Biochem Biophys Res Commun; 2009 May; 382(4):766-70. PubMed ID: 19324004
[TBL] [Abstract][Full Text] [Related]
11. Skeletal muscle mitochondrial FAT/CD36 content and palmitate oxidation are not decreased in obese women.
Holloway GP; Thrush AB; Heigenhauser GJ; Tandon NN; Dyck DJ; Bonen A; Spriet LL
Am J Physiol Endocrinol Metab; 2007 Jun; 292(6):E1782-9. PubMed ID: 17311893
[TBL] [Abstract][Full Text] [Related]
12. Disassociation of muscle triglyceride content and insulin sensitivity after exercise training in patients with Type 2 diabetes.
Bruce CR; Kriketos AD; Cooney GJ; Hawley JA
Diabetologia; 2004 Jan; 47(1):23-30. PubMed ID: 14673522
[TBL] [Abstract][Full Text] [Related]
13. Regulation of skeletal muscle sucrose, non-fermenting 1/AMP-activated protein kinase-related kinase (SNARK) by metabolic stress and diabetes.
Rune A; Osler ME; Fritz T; Zierath JR
Diabetologia; 2009 Oct; 52(10):2182-9. PubMed ID: 19652946
[TBL] [Abstract][Full Text] [Related]
14. Regulation of skeletal muscle hexokinase II by insulin in nondiabetic and NIDDM subjects.
Kruszynska YT; Mulford MI; Baloga J; Yu JG; Olefsky JM
Diabetes; 1998 Jul; 47(7):1107-13. PubMed ID: 9648835
[TBL] [Abstract][Full Text] [Related]
15. Hydrogen peroxide production is not primarily increased in human myotubes established from type 2 diabetic subjects.
Minet AD; Gaster M
J Clin Endocrinol Metab; 2011 Sep; 96(9):E1486-90. PubMed ID: 21733990
[TBL] [Abstract][Full Text] [Related]
16. Long-chain acyl-CoA synthetase 6 regulates lipid synthesis and mitochondrial oxidative capacity in human and rat skeletal muscle.
Teodoro BG; Sampaio IH; Bomfim LH; Queiroz AL; Silveira LR; Souza AO; Fernandes AM; Eberlin MN; Huang TY; Zheng D; Neufer PD; Cortright RN; Alberici LC
J Physiol; 2017 Feb; 595(3):677-693. PubMed ID: 27647415
[TBL] [Abstract][Full Text] [Related]
17. Fatty acid incubation of myotubes from humans with type 2 diabetes leads to enhanced release of beta-oxidation products because of impaired fatty acid oxidation: effects of tetradecylthioacetic acid and eicosapentaenoic acid.
Wensaas AJ; Rustan AC; Just M; Berge RK; Drevon CA; Gaster M
Diabetes; 2009 Mar; 58(3):527-35. PubMed ID: 19066312
[TBL] [Abstract][Full Text] [Related]
18. Perilipin 3 Differentially Regulates Skeletal Muscle Lipid Oxidation in Active, Sedentary, and Type 2 Diabetic Males.
Covington JD; Noland RC; Hebert RC; Masinter BS; Smith SR; Rustan AC; Ravussin E; Bajpeyi S
J Clin Endocrinol Metab; 2015 Oct; 100(10):3683-92. PubMed ID: 26171795
[TBL] [Abstract][Full Text] [Related]
19. Metabolic flexibility is conserved in diabetic myotubes.
Gaster M
J Lipid Res; 2007 Jan; 48(1):207-17. PubMed ID: 17062897
[TBL] [Abstract][Full Text] [Related]
20. Insulin resistance and the mitochondrial link. Lessons from cultured human myotubes.
Gaster M
Biochim Biophys Acta; 2007 Jul; 1772(7):755-65. PubMed ID: 17482433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
